[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-001", "question": "A 28-year-old male with a history of opioid use disorder presents with syncope. He admits to taking 'massive doses' of an over-the-counter anti-diarrheal medication to manage withdrawal symptoms. ECG shows sinus bradycardia at 45 bpm, a QTc interval of 680 ms, and intermittent broad-complex beats. He is hemodynamically stable but lethargic. Magnesium sulfate 2g IV is administered without change in the rhythm. Which of the following is the most appropriate next step in management?", "options": ["Option A: IV Amiodarone infusion", "Option B: IV Isoproterenol infusion", "Option C: IV Physostigmine", "Option D: Synchronized cardioversion", "Option E: IV Calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The patient has loperamide toxicity, which blocks cardiac sodium and potassium channels, causing QTc prolongation and wide-complex dysrhythmias. Unlike congenital Long QT (where isoproterenol is contraindicated), loperamide-induced TdP/QT prolongation is bradycardia-dependent; increasing the heart rate (chemical or electrical overdrive pacing) shortens the QT interval and prevents Torsades de Pointes. Amiodarone prolongs QT and is contraindicated.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with symptoms and ECG findings highly suggestive of loperamide toxicity. Loperamide, an opioid agonist, can cause significant QTc prolongation and torsades de pointes (TdP) when taken in supra-therapeutic doses. The ECG shows marked QTc prolongation (680 ms) and bradycardia, which are classic findings. The intermittent broad-complex beats could represent polymorphic ventricular tachycardia, a precursor to TdP.\n\nMagnesium sulfate is the first-line treatment for TdP, but it was ineffective in this case.\n\nLet's analyze the options:\n\nA. IV Amiodarone infusion: Amiodarone can prolong the QTc interval and is generally avoided in patients with significant QTc prolongation and TdP.\n\nB. IV Isoproterenol infusion: Isoproterenol is a beta-agonist that increases heart rate and can help shorten the QTc interval and suppress ventricular arrhythmias in the setting of bradycardia and QTc prolongation. This is a recommended treatment for TdP when magnesium is ineffective, especially in the presence of bradycardia.\n\nC. IV Physostigmine: Physostigmine is an acetylcholinesterase inhibitor that can be used for anticholinergic toxicity. While some anti-diarrheal medications have anticholinergic properties, the primary concern here is the opioid agonism of loperamide leading to QTc prolongation and TdP. Physostigmine can also cause bradycardia, which would be detrimental in this patient.\n\nD. Synchronized cardioversion: Synchronized cardioversion is indicated for hemodynamically unstable ventricular tachycardias or TdP. This patient is hemodynamically stable, making immediate cardioversion less appropriate as a first step after magnesium failure.\n\nE. IV Calcium gluconate: Calcium is used for hyperkalemia or hypocalcemia, neither of which is suggested by the presentation.\n\nGiven the persistent QTc prolongation and risk of TdP despite magnesium, and the presence of bradycardia, isoproterenol is the most appropriate next step to increase heart rate and potentially shorten the QTc interval.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-002", "question": "A 4-month-old female presents with failure to thrive, hypotonia, and a history of pyridoxine-responsive seizures. Laboratory evaluation reveals hypercalcemia, hypercalciuria, and a suppressed parathyroid hormone (PTH) level. Skeletal survey demonstrates diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses. Serum alkaline phosphatase (ALP) is 15 IU/L (Reference: 150-420 IU/L). Which of the following is the definitive treatment for this condition?", "options": ["Option A: High-dose Vitamin D supplementation", "Option B: Recombinant human parathyroid hormone (Teriparatide)", "Option C: Asfotase alfa", "Option D: Pyridoxine (Vitamin B6) monotherapy", "Option E: Bisphosphonate therapy"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Hypophosphatasia (HPP), caused by a loss-of-function mutation in the ALPL gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Low ALP leads to accumulation of inorganic pyrophosphate (an inhibitor of bone mineralization) and pyridoxal-5'-phosphate (causing B6-dependent seizures due to lack of dephosphorylation). Asfotase alfa is the enzyme replacement therapy. Vitamin D and bisphosphonates are contraindicated as they may worsen hypercalcemia and inhibit mineralization further.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with a constellation of symptoms and laboratory findings highly suggestive of **hypophosphatasia (HPP)**. Key indicators include:\n\n*   **Failure to thrive and hypotonia:** Common in infants with HPP due to impaired bone mineralization.\n*   **Pyridoxine-responsive seizures:** While not pathognomonic, these can occur in severe HPP, particularly in infants, and are sometimes responsive to pyridoxine.\n*   **Hypercalcemia and hypercalciuria:** Elevated calcium levels are seen in HPP due to impaired bone resorption and increased renal calcium reabsorption.\n*   **Suppressed PTH level:** This is a consequence of the hypercalcemia.\n*   **Skeletal survey findings:** Diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses are classic radiographic signs of rickets/osteomalacia seen in HPP.\n*   **Markedly low serum alkaline phosphatase (ALP):** This is the hallmark biochemical finding of HPP. ALP is crucial for bone mineralization, and its deficiency leads to the skeletal abnormalities. The provided ALP level of 15 IU/L is significantly below the reference range.\n\nNow let's evaluate the treatment options in the context of HPP:\n\n*   **A. High-dose Vitamin D supplementation:** Vitamin D is essential for calcium and phosphate absorption and bone mineralization. However, in HPP, the primary defect is in the enzyme responsible for cleaving inorganic pyrophosphate (PPi), which is catalyzed by tissue-nonspecific alkaline phosphatase (TNSALP). High-dose Vitamin D can worsen hypercalcemia and hypercalciuria in HPP and is not the definitive treatment.\n*   **B. Recombinant human parathyroid hormone (Teriparatide):** Teriparatide is a form of PTH used to stimulate bone formation. It is not indicated for HPP and could potentially exacerbate hypercalcemia.\n*   **C. Asfotase alfa:** Asfotase alfa is a first-in-class enzyme replacement therapy for HPP. It is a recombinant tissue-nonspecific alkaline phosphatase that directly addresses the underlying enzymatic deficiency by increasing circulating ALP activity, thereby improving bone mineralization and reducing toxic PPi accumulation. This is considered the definitive treatment for severe HPP.\n*   **D. Pyridoxine (Vitamin B6) monotherapy:** While pyridoxine responsiveness of seizures is noted, it is not the primary treatment for the underlying skeletal disease of HPP. Pyridoxine is a cofactor for TNSALP, and its supplementation can sometimes help with seizures in HPP, but it does not correct the enzyme deficiency or treat the bone disease.\n*   **E. Bisphosphonate therapy:** Bisphosphonates inhibit osteoclast activity and reduce bone resorption. They are used for conditions with excessive bone breakdown, but they do not address the impaired mineralization seen in HPP and can potentially worsen the condition by further reducing bone turnover.\n\nTherefore, asfotase alfa is the definitive treatment for this condition.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-003", "question": "A 68-year-old male presents with recurrent fevers, painful auricular chondritis, pulmonary infiltrates, and macrocytic anemia. He has been treated for 'refractory relapsing polychondritis' without success. Bone marrow biopsy reveals hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells. Which of the following is the most likely diagnosis?", "options": ["Option A: Myelodysplastic Syndrome (MDS) with excess blasts", "Option B: VEXAS syndrome", "Option C: Sweet syndrome", "Option D: Polyarteritis Nodosa", "Option E: Granulomatosis with Polyangiitis"], "answer": "B", "answer_index": 1, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in the UBA1 gene. It presents in older men with inflammatory features (chondritis, vasculitis, fevers) and hematologic abnormalities (macrocytic anemia). The pathognomonic finding is vacuoles in myeloid and erythroid precursors in the bone marrow.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with a constellation of symptoms and findings that strongly suggest VEXAS syndrome. Let's break down why:\n\n*   **Age and Sex:** A 68-year-old male is within the typical demographic for VEXAS syndrome.\n*   **Recurrent Fevers and Painful Auricular Chondritis:** These are hallmark features of relapsing polychondritis, which the patient was initially treated for. VEXAS syndrome is known to be associated with or mimic relapsing polychondritis.\n*   **Pulmonary Infiltrates:** This indicates systemic inflammation affecting the lungs, consistent with a systemic inflammatory disorder.\n*   **Macrocytic Anemia:** This is a common hematological finding in VEXAS syndrome.\n*   **Bone Marrow Biopsy Findings:** Hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells is a pathognomonic finding for VEXAS syndrome. This is often referred to as \"vacuolated myeloid and erythroid precursors.\"\n\nNow let's consider why the other options are less likely:\n\n*   **A. Myelodysplastic Syndrome (MDS) with excess blasts:** While MDS can cause macrocytic anemia and bone marrow hypercellularity, the prominent cytoplasmic vacuoles in myeloid and erythroid precursors are not typical of MDS with excess blasts. Furthermore, the specific inflammatory features (fevers, chondritis) are less directly explained by MDS alone.\n*   **C. Sweet syndrome:** Sweet syndrome is an acute febrile neutrophilic dermatosis. While it can be associated with systemic symptoms like fever and sometimes pulmonary involvement, the prominent auricular chondritis and the specific bone marrow findings (vacuolated precursors) are not characteristic of Sweet syndrome.\n*   **D. Polyarteritis Nodosa:** Polyarteritis nodosa is a systemic vasculitis that typically affects medium-sized arteries. While it can cause fever and organ involvement (including lungs), painful auricular chondritis is not a typical feature, and the bone marrow findings are not specific to this condition.\n*   **E. Granulomatosis with Polyangiitis:** This is another systemic vasculitis, characterized by granulomas and vasculitis affecting small to medium-sized vessels, often involving the upper respiratory tract, lungs, and kidneys. While it can cause pulmonary infiltrates and fever, painful auricular chondritis is not a primary feature, and the bone marrow findings are not specific.\n\nThe combination of relapsing inflammatory symptoms (mimicking relapsing polychondritis), macrocytic anemia, and the specific bone marrow findings of vacuolated myeloid and erythroid precursors strongly points to VEXAS syndrome.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-004", "question": "A 55-year-old female with chronic malnutrition and a history of chronic acetaminophen use for osteoarthritis presents with altered mental status. Arterial blood gas shows pH 7.28, pCO2 28 mmHg, HCO3 12 mEq/L. The anion gap is 24. Lactate is 0.9 mmol/L, serum ketones are negative, and creatinine is 1.1 mg/dL. Toxic alcohol screen is negative. Which of the following is the most appropriate therapeutic intervention?", "options": ["Option A: IV Fomepizole", "Option B: IV Sodium Bicarbonate", "Option C: N-acetylcysteine", "Option D: Hemodialysis", "Option E: Thiamine and Dextrose"], "answer": "C", "answer_index": 2, "explanation": "This patient has high anion gap metabolic acidosis due to 5-oxoproline (pyroglutamic acid) accumulation. This occurs in the setting of glutathione depletion (malnutrition, acetaminophen use), which disrupts the gamma-glutamyl cycle. N-acetylcysteine replenishes glutathione stores, restoring the feedback loop and halting 5-oxoproline production. Fomepizole is for toxic alcohols, which were ruled out.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with a metabolic acidosis with a high anion gap (24) and a low bicarbonate (12 mEq/L). The pH is 7.28, indicating acidosis. The pCO2 of 28 mmHg suggests a compensatory respiratory alkalosis.\n\nLet's analyze the potential causes of high anion gap metabolic acidosis:\n*   **MUDPILES:**\n    *   Methanol: Toxic alcohol screen is negative.\n    *   Uremia: Creatinine is 1.1 mg/dL, which is not significantly elevated to cause uremic acidosis.\n    *   Diabetic Ketoacidosis (DKA): Serum ketones are negative.\n    *   Paraldehyde: Not mentioned.\n    *   Iron, Isoniazid: Not suggested by the presentation.\n    *   Lactic Acidosis: Lactate is 0.9 mmol/L, which is normal.\n    *   Ethylene Glycol: Toxic alcohol screen is negative.\n    *   Salicylates: Chronic acetaminophen use is mentioned, and acetaminophen overdose can lead to salicylate toxicity, which causes a mixed acid-base disorder (respiratory alkalosis and high anion gap metabolic acidosis).\n\nGiven the history of chronic acetaminophen use and the presentation of altered mental status with a high anion gap metabolic acidosis, salicylate toxicity is a strong possibility, even if not explicitly stated as an overdose. Acetaminophen itself is not a salicylate, but it can be metabolized to p-aminophenol, which can cause toxicity, and chronic high doses can lead to liver damage. However, the question specifically mentions chronic acetaminophen use, and the anion gap is high. Salicylate toxicity is a known cause of high anion gap metabolic acidosis and altered mental status.\n\nLet's evaluate the options based on this suspicion:\n\n*   **A. IV Fomepizole:** Fomepizole is an antidote for methanol and ethylene glycol poisoning. It is not indicated for salicylate toxicity.\n*   **B. IV Sodium Bicarbonate:** Sodium bicarbonate is used to treat metabolic acidosis. While it can be used in salicylate toxicity, it is typically reserved for severe cases with pH < 7.1 or when there is significant cardiovascular compromise. The pH is 7.28, which is not critically low. Furthermore, bicarbonate can worsen CNS penetration of salicylates.\n*   **C. N-acetylcysteine:** N-acetylcysteine (NAC) is the antidote for acetaminophen overdose. While the patient has a history of chronic acetaminophen use, the primary concern raised by the ABG and anion gap is not direct acetaminophen toxicity but rather a potential complication or a co-ingestion. However, chronic high-dose acetaminophen use can lead to liver damage, and NAC is the standard of care for acetaminophen toxicity. If the altered mental status is due to acetaminophen-induced hepatotoxicity, NAC would be indicated. Given the history and the possibility of a mixed picture or complications from chronic use, NAC is a strong contender.\n*   **D. Hemodialysis:** Hemodialysis is indicated for severe salicylate toxicity (serum salicylate level > 100 mg/dL), severe renal failure, or when there is altered mental status or coma unresponsive to other measures. It can also be used for severe metabolic acidosis (pH < 7.1). While the patient has altered mental status, the pH is not critically low, and we don't have a salicylate level.\n*   **E. Thiamine and Dextrose:** Thiamine and dextrose are used to treat Wernicke's encephalopathy, which can occur in chronic malnutrition. While the patient has chronic malnutrition, the primary presentation is altered mental status with a high anion gap metabolic acidosis, which is not the typical presentation of Wernicke's. However, thiamine deficiency can exacerbate lactic acidosis, but the lactate is normal here.\n\nReconsidering the options: The high anion gap metabolic acidosis and altered mental status in the context of chronic acetaminophen use strongly suggest salicylate toxicity as a complication or co-ingestion, or potentially a severe consequence of chronic acetaminophen use leading to metabolic derangement. However, the question states \"chronic acetaminophen use,\" not acute overdose. Acetaminophen itself can cause a high anion gap metabolic acidosis, particularly in overdose or with chronic high doses leading to hepatotoxicity and subsequent metabolic derangements. N-acetylcysteine is the antidote for acetaminophen toxicity.\n\nLet's re-evaluate the possibility of salicylate toxicity. Acetaminophen is N-acetyl-p-aminophenol. Salicylates are acetylsalicylic acid. They are different compounds. However, chronic acetaminophen use can lead to liver damage, and liver failure can cause metabolic acidosis. Also, some sources mention that severe acetaminophen overdose can lead to a high anion gap metabolic acidosis due to the accumulation of toxic metabolites like p-aminophenol.\n\nGiven the options and the presentation:\nThe high anion gap (24) and low bicarbonate (12) with a pH of 7.28 clearly indicate a significant metabolic acidosis.\nThe normal lactate and negative ketones rule out common causes of high anion gap acidosis.\nThe negative toxic alcohol screen rules out methanol and ethylene glycol.\n\nThis leaves us with considering the consequences of chronic acetaminophen use. While acetaminophen itself is not a salicylate, chronic high doses can lead to hepatotoxicity. Severe hepatotoxicity can result in metabolic acidosis. N-acetylcysteine is the antidote for acetaminophen toxicity.\n\nLet's consider the possibility that the question implies a complication of chronic acetaminophen use that leads to a high anion gap acidosis. N-acetylcysteine is the definitive treatment for acetaminophen toxicity. If the altered mental status and acidosis are due to acetaminophen-induced hepatotoxicity, then NAC is the correct intervention.\n\nIf we strictly interpret \"chronic acetaminophen use\" as the underlying condition, and the metabolic acidosis and altered mental status are a consequence of this, then N-acetylcysteine is the most appropriate intervention to address the potential underlying acetaminophen toxicity or its sequelae.\n\nLet's consider if there's any other interpretation. If the patient was taking salicylates concurrently, then salicylate toxicity would be the primary concern. However, the question only mentions acetaminophen.\n\nGiven the options, and the strong association of chronic acetaminophen use with potential liver damage and subsequent metabolic derangements, N-acetylcysteine is the most direct therapeutic intervention related to the stated history.\n\nFinal consideration: The anion gap is 24, which is significantly elevated. The bicarbonate is 12. This is a severe metabolic acidosis. While the pH is 7.28, the anion gap is the key indicator of the severity and potential cause.\n\nLet's assume the question is pointing towards a complication of chronic acetaminophen use. N-acetylcysteine is the antidote for acetaminophen toxicity.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with symptoms suggestive of a prolactinoma (amenorrhea, galactorrhea, and elevated prolactin levels). The elevated prolactin level of 145 ng/mL is significantly above the reference range. While the macroadenoma is large (4.5 cm) and invades the cavernous sinus, the primary driver of the symptoms is the hyperprolactinemia.\n\nOption A: Transsphenoidal resection is a surgical option, but medical management with dopamine agonists is typically the first-line treatment for symptomatic prolactinomas, especially when prolactin levels are elevated. Surgery is usually reserved for cases that are refractory to medical therapy, have significant mass effect causing visual compromise or other neurological symptoms, or when rapid decompression is needed.\n\nOption B: Stereotactic radiosurgery is generally used for residual tumors after surgery or for patients who are not surgical candidates, and it is not the initial treatment for a prolactinoma.\n\nOption C: Measurement of prolactin in diluted serum is important to rule out the \"hook effect.\" The hook effect occurs when very high levels of a hormone saturate the antibody binding sites in an immunoassay, leading to a falsely low measurement. In this case, the prolactin level is very high, and it's crucial to confirm this is not an artifact of the assay. If the prolactin level remains high after dilution, it confirms true hyperprolactinemia.\n\nOption D: Octreotide scintigraphy is used to localize neuroendocrine tumors, particularly carcinoid tumors and somatostatinoma, and is not relevant for pituitary adenomas.\n\nOption E: Bilateral inferior petrosal sinus sampling is used to differentiate between pituitary and ectopic sources of ACTH in Cushing's disease and is not indicated here.\n\nGiven the very high prolactin level, the most appropriate next step is to confirm the accuracy of this measurement by ruling out the hook effect. If the hook effect is ruled out and the prolactin level remains significantly elevated, then medical management with a dopamine agonist would be the next step. However, before initiating treatment, confirming the prolactin level is paramount.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-006", "question": "A 60-year-old male with a history of radiation therapy for Hodgkin lymphoma presents with signs of cardiac tamponade. Pericardiocentesis is performed, draining 800 mL of bloody fluid. Following drainage, the intrapericardial pressure drops to 0 mmHg, but the right atrial pressure remains elevated at 18 mmHg with a prominent y-descent that was previously absent. Which of the following is the most likely diagnosis?", "options": ["Option A: Incomplete drainage of the effusion", "Option B: Effusive-constrictive pericarditis", "Option C: Right ventricular infarction", "Option D: Pulmonary embolism", "Option E: Flash pulmonary edema"], "answer": "B", "answer_index": 1, "explanation": "Effusive-constrictive pericarditis is characterized by concurrent tamponade and constriction. The visceral pericardium is thickened and constrictive. Initially, the effusion masks the constriction (tamponade physiology: blunted y-descent). After drainage, the tamponade resolves, but the underlying constriction becomes manifest (elevated RA pressure with prominent y-descent). Treatment requires visceral pericardiectomy.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with signs of cardiac tamponade, which is relieved by pericardiocentesis. However, the persistence of an elevated right atrial pressure (18 mmHg) with a prominent y-descent after drainage suggests a restrictive process. A prominent y-descent in the right atrial pressure tracing is characteristic of rapid ventricular filling, which is impaired in constrictive pericarditis. The history of radiation therapy for Hodgkin lymphoma is a known risk factor for constrictive pericarditis.\n\nLet's analyze the options:\n\nA. Incomplete drainage of the effusion: While incomplete drainage could lead to persistent elevated intrapericardial pressure, the prompt states the intrapericardial pressure dropped to 0 mmHg, indicating successful drainage of the effusion itself. The persistent elevated right atrial pressure and new y-descent point to a different issue.\n\nB. Effusive-constrictive pericarditis: This diagnosis fits the clinical picture. The initial presentation was tamponade due to the effusion. After drainage, the underlying constrictive process becomes apparent, characterized by elevated right atrial pressure and a prominent y-descent, indicating impaired diastolic filling due to pericardial restriction.\n\nC. Right ventricular infarction: While RV infarction can lead to elevated right atrial pressure, it typically doesn't present with a prominent y-descent in the absence of tamponade and is not directly explained by the history of radiation therapy in this context.\n\nD. Pulmonary embolism: Massive PE can cause elevated right atrial pressure, but the prominent y-descent is not a typical finding, and the history of radiation therapy is less directly relevant.\n\nE. Flash pulmonary edema: This is a condition of acute left ventricular failure leading to pulmonary congestion. It would typically manifest with elevated pulmonary venous pressures and potentially elevated left atrial and right atrial pressures, but the prominent y-descent is not a hallmark of this condition.\n\nTherefore, effusive-constrictive pericarditis is the most likely diagnosis, where the effusion initially caused tamponade, and after drainage, the underlying constriction of the pericardium is revealed.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-007", "question": "A 65-year-old male is admitted to the ICU for sedation and mechanical ventilation. On day 3 of a continuous propofol infusion, he develops new Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3. Labs reveal severe metabolic acidosis (pH 7.18), Lactate 9 mmol/L, and CK 8,000 U/L. Echocardiogram shows new global hypokinesis. Which of the following is the most likely diagnosis?", "options": ["Option A: Acute Anterior ST-Elevation MI", "Option B: Massive Pulmonary Embolism", "Option C: Propofol Infusion Syndrome", "Option D: Brugada Syndrome unmasked by fever", "Option E: Septic Cardiomyopathy"], "answer": "C", "answer_index": 2, "explanation": "Propofol Infusion Syndrome (PRIS) is a rare but lethal complication of high-dose/long-duration propofol. It causes mitochondrial failure leading to rhabdomyolysis, metabolic acidosis, heart failure, and characteristic ECG changes (often Brugada-like pattern: RBBB with coved ST elevation). Immediate cessation of propofol and supportive care is required.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with a constellation of symptoms and lab findings that strongly suggest Propofol Infusion Syndrome (PRIS). Let's break down why:\n\n*   **New Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3:** This ECG pattern, particularly the ST elevation in V1-V3, can be seen in various conditions, including MI and PE. However, in the context of propofol, it's a recognized feature of PRIS.\n*   **Severe metabolic acidosis (pH 7.18) and Lactate 9 mmol/L:** These are hallmarks of severe cellular dysfunction and impaired aerobic metabolism, consistent with mitochondrial toxicity, a key mechanism in PRIS.\n*   **CK 8,000 U/L:** Elevated creatine kinase indicates muscle damage, which can occur in PRIS due to rhabdomyolysis.\n*   **New global hypokinesis on echocardiogram:** This points to impaired cardiac function, which is a common manifestation of PRIS.\n*   **Continuous propofol infusion for 3 days:** PRIS is typically associated with prolonged infusions of propofol, especially at higher doses.\n\nLet's consider why the other options are less likely:\n\n*   **A. Acute Anterior ST-Elevation MI:** While the ECG findings can mimic an MI, the severe metabolic acidosis, elevated lactate, and the context of propofol infusion make PRIS a more unifying diagnosis. An MI would typically not cause such profound metabolic derangements on its own.\n*   **B. Massive Pulmonary Embolism:** A massive PE can cause right heart strain, leading to ECG changes and hemodynamic compromise. However, the severe metabolic acidosis and elevated lactate are not as directly explained by PE as they are by mitochondrial dysfunction in PRIS.\n*   **D. Brugada Syndrome unmasked by fever:** Brugada syndrome is a genetic disorder that can cause characteristic ECG changes. While fever can unmask it, the other findings (severe acidosis, high lactate, elevated CK, global hypokinesis) are not typical features of Brugada syndrome itself.\n*   **E. Septic Cardiomyopathy:** Sepsis can lead to myocardial dysfunction and metabolic derangements. However, the specific ECG findings (RBBB with coved ST elevation in V1-V3) are more suggestive of PRIS, and the direct link to propofol infusion is a strong indicator.\n\nThe combination of prolonged propofol infusion, cardiac dysfunction, metabolic acidosis, elevated lactate, and muscle injury is highly characteristic of Propofol Infusion Syndrome.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-008", "question": "A 58-year-old male with dyslipidemia develops proximal muscle weakness and myalgias. His CK is 8,500 U/L. Atorvastatin is discontinued. Two months later, his weakness has progressed, and CK remains elevated at 9,200 U/L. Muscle biopsy shows necrotizing myopathy with minimal inflammation. Testing for anti-HMGCR antibodies is positive. Which of the following is the most appropriate management?", "options": ["Option A: Switch to Rosuvastatin", "Option B: Initiate Coenzyme Q10 supplementation", "Option C: Initiate IVIG and/or systemic immunosuppression", "Option D: Observation for spontaneous resolution", "Option E: Dantrolene sodium"], "answer": "C", "answer_index": 2, "explanation": "This patient has Statin-Associated Autoimmune Myopathy (SAAM), specifically anti-HMGCR positive necrotizing myopathy. Unlike self-limited statin myotoxicity, this is an autoimmune process that progresses despite statin cessation. It requires aggressive immunosuppression (steroids, IVIG, Rituximab, or Methotrexate) to prevent permanent muscle loss.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with symptoms suggestive of statin-induced myopathy, but the persistent and worsening weakness and elevated CK levels despite discontinuation of atorvastatin, along with the positive anti-HMGCR antibodies and necrotizing myopathy on biopsy, strongly indicate immune-mediated necrotizing myopathy (IMNM) associated with statins. This condition is distinct from typical statin-induced myopathy and requires immunosuppressive therapy.\n\nOption A is incorrect because switching to another statin like rosuvastatin is likely to exacerbate the condition, as the underlying issue is an autoimmune response to HMGCR, the target of all statins.\n\nOption B is incorrect. While Coenzyme Q10 is sometimes used in statin-induced myopathy, it is not the primary or most effective treatment for IMNM.\n\nOption C is correct. IVIG (intravenous immunoglobulin) and/or systemic immunosuppression (e.g., corticosteroids, azathioprine) are the mainstay of treatment for anti-HMGCR antibody-positive necrotizing myopathy. These therapies aim to suppress the autoimmune attack on muscle.\n\nOption D is incorrect. Observation for spontaneous resolution is not appropriate given the progressive nature of the weakness and the autoimmune etiology.\n\nOption E is incorrect. Dantrolene sodium is a muscle relaxant used for conditions like malignant hyperthermia and spasticity, and it is not indicated for IMNM.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-009", "question": "A 2-week-old XX infant presents with ambiguous genitalia (virilization). Vital signs reveal a blood pressure of 96/60 mmHg (hypertensive for age). Laboratory evaluation shows Sodium 136 mEq/L and Potassium 2.9 mEq/L. 17-hydroxyprogesterone is elevated. Which of the following enzyme deficiencies is the most likely cause?", "options": ["Option A: 21-hydroxylase deficiency", "Option B: 11-beta-hydroxylase deficiency", "Option C: 17-alpha-hydroxylase deficiency", "Option D: 3-beta-hydroxysteroid dehydrogenase deficiency", "Option E: P450 oxidoreductase deficiency"], "answer": "B", "answer_index": 1, "explanation": "Congenital Adrenal Hyperplasia due to 11-beta-hydroxylase deficiency blocks cortisol synthesis, shunting precursors to androgens (causing virilization in females) and accumulating 11-deoxycorticosterone (DOC). DOC is a potent mineralocorticoid, leading to salt retention, hypertension, and hypokalemia. This distinguishes it from the more common 21-hydroxylase deficiency, which causes salt-wasting (hypotension, hyperkalemia).", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with ambiguous genitalia (virilization) in a 2-week-old XX infant, which points towards a disorder of sex development, specifically congenital adrenal hyperplasia (CAH). The elevated blood pressure (hypertensive for age) and electrolyte abnormalities (low potassium, normal sodium) are crucial clues. The elevated 17-hydroxyprogesterone is a hallmark of CAH.\n\nLet's analyze the options:\n\nA. **21-hydroxylase deficiency:** This is the most common form of CAH. It leads to a buildup of androgens, causing virilization in XX infants. Depending on the severity, it can also cause salt-wasting (hyponatremia, hyperkalemia) or simple virilizing forms. However, hypertension is not a typical feature of 21-hydroxylase deficiency.\n\nB. **11-beta-hydroxylase deficiency:** This form of CAH also leads to androgen excess and virilization in XX infants. A key distinguishing feature is the accumulation of 11-deoxycorticosterone (DOC), a mineralocorticoid that causes sodium retention and potassium excretion, leading to hypertension and hypokalemia. This matches the patient's presentation of virilization, hypertension, and hypokalemia.\n\nC. **17-alpha-hydroxylase deficiency:** This deficiency leads to a lack of cortisol and sex hormones. Instead, there is an accumulation of mineralocorticoids (DOC and corticosterone), causing hypertension and hypokalemia. However, it typically results in female pseudohermaphroditism (lack of virilization) in XX individuals and delayed puberty in XY individuals due to lack of androgens. This contradicts the virilization seen in the patient.\n\nD. **3-beta-hydroxysteroid dehydrogenase deficiency:** This deficiency affects the synthesis of all steroid hormones, including cortisol, aldosterone, and androgens. It can lead to salt-wasting and ambiguous genitalia. However, it typically results in *underproduction* of androgens, leading to *lack* of virilization in XX infants, or even feminization in XY infants. This is inconsistent with the patient's virilization.\n\nE. **P450 oxidoreductase deficiency:** This is a rare disorder that can affect multiple P450 enzymes, including those involved in steroidogenesis. It can lead to a variety of presentations, including CAH. However, 11-beta-hydroxylase deficiency is a more direct and common explanation for the specific constellation of symptoms presented.\n\nConsidering the virilization, hypertension, and hypokalemia, 11-beta-hydroxylase deficiency is the most likely diagnosis. The elevated 17-hydroxyprogesterone is also consistent with CAH, and in 11-beta-hydroxylase deficiency, the precursor 17-hydroxyprogesterone can accumulate due to the block further down the pathway.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-010", "question": "A 45-year-old male on chronic amiodarone therapy for atrial fibrillation presents with weight loss and palpitations. TSH is <0.01 mIU/L and Free T4 is elevated. He has no neck pain. Thyroid ultrasound with color flow Doppler reveals an absence of vascularity within the thyroid parenchyma. Which of the following is the most appropriate initial treatment?", "options": ["Option A: Methimazole", "Option B: Propylthiouracil", "Option C: Prednisone", "Option D: Radioactive Iodine ablation", "Option E: Potassium Perchlorate"], "answer": "C", "answer_index": 2, "explanation": "This is Type 2 Amiodarone-Induced Thyrotoxicosis (AIT), which is a destructive thyroiditis caused by direct cytotoxic effects of the drug. The key differentiator from Type 1 AIT (Jod-Basedow/iodine-induced synthesis) is the Doppler flow: Type 1 has increased vascularity, while Type 2 has absent vascularity. Type 2 is treated with high-dose glucocorticoids. Thionamides (Methimazole) are ineffective for destructive thyroiditis.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with symptoms of hyperthyroidism (weight loss, palpitations) and laboratory findings consistent with it (low TSH, elevated Free T4). The absence of vascularity on thyroid ultrasound is a key finding. Amiodarone is known to cause thyroid dysfunction, both hypothyroidism and hyperthyroidism. Amiodarone-induced hyperthyroidism (AIH) can be divided into two types: Type 1, which is due to excess iodine in amiodarone leading to increased thyroid hormone synthesis, and Type 2, which is due to amiodarone-induced thyroiditis causing release of preformed thyroid hormones. The absence of vascularity on Doppler ultrasound is highly suggestive of Type 2 AIH, which is an inflammatory process.\n\nLet's analyze the options:\n\nA. Methimazole and B. Propylthiouracil (PTU) are antithyroid drugs that inhibit thyroid hormone synthesis. They are generally effective for Type 1 AIH but are less effective for Type 2 AIH because the problem is not overproduction but release of stored hormone.\n\nC. Prednisone is a corticosteroid. Corticosteroids are the treatment of choice for Type 2 AIH because they suppress the inflammatory process that leads to thyroid hormone release.\n\nD. Radioactive Iodine ablation is used to permanently destroy thyroid tissue and is typically reserved for patients with Graves' disease or toxic multinodular goiter who are not candidates for surgery or antithyroid drugs, or for those who have failed other treatments. It is generally contraindicated in AIH, especially Type 2, as it can worsen the inflammatory process.\n\nE. Potassium Perchlorate inhibits iodide uptake by the thyroid gland. It is primarily used for Type 1 AIH when there is iodine overload. It is not the primary treatment for Type 2 AIH.\n\nGiven the presentation suggestive of Type 2 AIH (absence of vascularity on Doppler), prednisone is the most appropriate initial treatment.\n\nThe answer is (C)"}]